Physician profile

Philip E Madrid

Adult Medicine · Orange, CA

NPI 1578523692

$7,601.61

in general payments reported to CMS, 2019-2025

28 companies · $150 in 2025

The $150 reported for 2025 was more than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,736.24
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$150.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Amgen INC. $1,834.31 2019-2024 Repatha, Otezla, Krystexxa
Astrazeneca Pharmaceuticals Lp $1,366.00 2019-2024 Airsupra, Farxiga
Glaxosmithkline, LLC. $865.23 2019-2024 Trelegy Ellipta, Arexvy
Novo Nordisk INC $626.63 2019-2024 Ozempic, Rybelsus
Bayer Healthcare Pharmaceuticals INC. $359.95 2022-2024
Janssen Pharmaceuticals, INC $316.01 2019-2023 Xarelto
Lilly USA, LLC $283.30 2019-2024 Mounjaro
Allergan, INC. $257.85 2019-2020
Lexicon Pharmaceuticals, INC. $256.21 2023-2024 Inpefa
Merck Sharp & Dohme LLC $182.40 2022-2024 Verquvo, Capvaxive, Gardasil 9
Pfizer INC. $173.05 2019-2024
Sanofi-Aventis U.S. LLC $164.02 2019-2025
Radius Health, INC. $149.34 2019
Gilead Sciences, INC. $123.59 2019-2024
Daiichi Sankyo INC. $99.65 2019
Show all 28 companies
CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $97.72 2022-2024
Dexcom, INC. $83.33 2021-2023 Dexcom G6 Transmitter
Inari Medical, INC. $77.58 2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $68.51 2019-2023 Xifaxan, Trulance
Teva Pharmaceuticals USA, INC. $64.01 2019
Sumitomo Pharma America, INC. $29.65 2023 Gemtesa
Dynavax Technologies Corporation $27.10 2019
Takeda Pharmaceuticals U.S.A., INC. $25.26 2019
Boehringer Ingelheim Pharmaceuticals, INC. $16.36 2019
E.R. Squibb & Sons, L.L.C. $16.09 2019
Pacira Therapeutics, INC. $15.49 2019
Sanofi Pasteur INC. $11.76 2019
Astellas Pharma US INC $11.21 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Philip E Madrid

$7,601.61

in general payments reported 2019-2025

Years
2019-2025
Top company
Amgen INC.
Context
The $150 reported for 2025 was more than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).

https://glasscript.com/doctor/116222/philip-e-madrid

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.